Moving the Needle provides quarterly updates from PATH's Center for
Vaccine Innovation and Access (CVIA) on our vaccine development efforts, as well as related supporting work, such as developing human challenge models, building capacity of developing - country vaccine manufacturers, and evaluating new adjuvants and other novel vaccine techno
Vaccine Innovation and Access (CVIA) on our
vaccine development efforts, as well as related supporting work, such as developing human challenge models, building capacity of developing - country vaccine manufacturers, and evaluating new adjuvants and other novel vaccine techno
vaccine development efforts, as well as related supporting work, such as developing human challenge models, building capacity of developing - country
vaccine manufacturers, and evaluating new adjuvants and other novel vaccine techno
vaccine manufacturers, and evaluating new
adjuvants and other
novel vaccine techno
vaccine technologies.